Since the report by Young et al in 19798 numerous authors2 3 v have described, by indirect immunofluorescence in rheumatoid sera, antibodies able to label the stratum comeum of rat oesophagus epithelium. These anti-stratum corneum antibodies, generally called 'antikeratin antibodies',* have been found to be a more specific marker than the usual serological indexes of the disease, and their detection has been proposed as a diagnostic test for RA. In all these studies, however, the detection thresholds for antikeratin antibodies have been arbitrarily chosen and this has introduced some 'Antikeratin antibodies' in rheumatoid arthritis 713 variation in the results of different authors in the evaluation of the diagnostic sensitivity and specificity of the test.
We studied IgG and IgM antibodies to rat oesophagus epithelium, including antikeratin antibodies, in a large number of serum samples from patients with well characterised rheumatic diseases. Like previous authors we used an indirect immunofluorescence assay, but to determine objectively the diagnostic sensitivity and specificity of antikeratin antibodies we used an original semiquantitative method to study their labelling patterns in detail with regard to the other antiepithelial antibodies. This method permitted accurate grading of the fluorescence intensity without previous choice of a positivity threshold and therefore determination of a precise antikeratin antibody titre-like value. In addition, we investigated relations between antikeratin antibodies and several clinical and serological indexes of the disease. Lastly, we analysed previous international reports and determined the usefulness of antikeratin antibodies in the diagnosis of RA, and their relations with other features of the disease for all the results of tested sera published since 1979. Patients and methods
PATIENTS
From among 3396 serum samples from 1749 patients with rheumatic diseases assayed during the past two years, we selected and studied 528 samples obtained from 528 patients with perfectly characterised diseases according to clinical, radiographic, and biological criteria (Table 1) . The patients could be The slides were rinsed twice in PBS and mounted with Fluoprep medium (Bio-Merieux, Lyon, France). Observations were performed on an Olympus-BH2 microscope with ultraviolet epiillumination, and photographs were taken with an Olympus-OM4 camera (Tokyo, Japan). The fluorescence intensity of each histological compartment of the comified stratified squamous epithelium of the rat oesophagus (Fig. 1A) -that is, stratum corneum, stratum spinosum, and stratum basale, was separately estimated by two readers, who did not know the clinical context. Results were estimated on a semiquantitative scale from 0 to 4 and the results of the two readers were summed (final range 0-8). On such a scale the accuracy of the human eye reading has been found to be better than 0 50 (data not shown). Therefore a 0-25 step was chosen so that measurement accuracy was not limited by the scale inaccuracy. The reliability of the semiquantitative evaluation was ensured in each assay by a previous reading of three reference sera of known intensity, acting as interassay controls. Moreover, three other known serum samples permitted the stability of the evaluation within each assay to be controlled. antibody detection in RA to be assessed. The positive predictive value-that is, the probability of the diagnosis (TP/(TP+FP)), and the negative predictive value-that is, the probability of the diagnosis exclusion (TN/(TN+FN)), depending on RA prevalence, allowed the usefulness of the test to be determined in the actual clinical conditions of diagnostic use.
Results
All 528 serum samples were assayed for IgG and IgM antibodies to rat oesophagus. The antibodies of both classes were analysed histologically by morphological typing of the labelling in each compartment of the epithelium (stratum corneum, stratum spinosum, stratum basale) and semiquantitatively by grading of the fluorescence intensity separately in the three compartments. For both IgG and IgM antibodies, most serum samples belonging to all the diagnostic groups, labelled the three epithelial compartments, but with large interindividual variations in both morphological labelling pattern and fluorescence intensity (Fig. 1 ).
HISTOLOGICAL ANALYSIS OF IgG AND IgM ANTIBODIES TO RAT OESOPHAGUS

EPITHELIUM
IgG antibodies From the labelling of the stratum corneum and stratum spinosum produced by IgG antibodies, four typical patterns were distinguished (Table 2) ; two predominated. Intense, regular, linear, laminated labelling restricted to the stratum comeum was obtained almost exclusively with RA sera. Weak, diffuse, cytoplasmic labelling of the stratum basale and the stratum spinosum associated with weak and diffuse labelling of the stratum comeum was produced by numerous serum samples belonging to every diagnostic group (Fig. 1E ). Besides these two predominant forms, we also found, but rarely, two other patterns: intense, linear, laminated labelling of the stratum comeum associated with equally intense, diffuse, cytoplasmic labelling of the stratum spinosum. This was produced by only four serum samples (Fig. 1C) . Lastly, intense, diffuse, cytoplasmic labelling restricted to the stratum spinosum was given by only two sera (Fig. 1D ). These two last patterns were independent of disease. In many cases pericellular labelling of the stratum basale, isolated or superimposed on these various patterns, was found. This morphological analysis placed a high proportion of serum samples (90-7%) in four histological classes. The other serum samples (9-3%) produced labelling patterns intermediate between these four types. The more frequently found showed laminated but weak labelling of the stratum corneum associated with equally intense diffuse cytoplasmic labelling of the two other epithelial compartments. Because of the obvious high disease specificity of the exclusive labelling of the stratum corneum, and because of the existence of intermediate patterns including labelling of the stratum corneum, a semiquantitative estimation of its fluorescence intensity was carried out to determine the anti-stratum corneum antibody (or antikeratin antibody) titre-like value necessary for a diagnosis of RA. (Fig. 2A) . The mean value of IgG antikeratin antibodies was much higher in RA sera than in non-RA sera, however (Mann-Whitney U test=6-23; p <10-8). Furthermore, the fluorescence intensity was restricted to low values with the controls (non-RA), whereas it extended all along the scale, from 0 to 7.75, with RA sera, showing that high titre IgG antikeratin antibodies are specific for RA ( Fig. 2A) . For each IgG antikeratin antibody semiquantitative value the diagnostic sensitivity and specificity were computed. The resulting curves showed that specificity increased rapidly up to a fluorescence intensity of 1.50 (Fig. 2B) . At a fluorescence intensity of 1-50, 1-75, and 2-00 the specificity was 95-43%, 98%, and 99-14% and the sensitivity 56-18%, 47-75%, and 43-26%, respectively (Table  3) . At fluorescence intensities higher than 3.25, although the sensitivity became weaker than 20%, the specificity reached 100%. Thus high titre IgG antikeratin antibodies were found to be pathognomonic for RA. For all further statistical analyses we chose 2 00 as a threshold because it gave a specificity greater than 99% without serious loss of sensitivity. Above this threshold, the four sera giving a non-RA-specific pattern (Table 2) were excluded, and thus only three false positive sera remained (0-86% of non-RA sera): 1 systemic lupus erythematosus (2.00), 1 ankylosing spondylitis , and 1 Paget's disease . Moreover, IgG antikeratin antibodies were found to enhance the probability of RA diagnosis from 33-71% (prevalence of RA in our the intense linear laminated labelling restricted to the stratum corneum was highly specific for RA, while the weak diffuse labelling of the three epithelial compartments was found in some RA sera but also in numerous non-RA sera. Of the two other typical but scarce patterns, the exclusive labelling of the stratum spinosum was of no diagnostic value, while the equally intense labelling of stratum spinosum and stratum corneum permitted discrimination between the related antibodies and the RA specific antibodies and prevented the related sera from being considered as false positives. The patterns intermediate between these typical forms could result from the simultaneous presence of antibodies of different specificities-for example, low titre RA specific IgG antikeratin antibodies and other antiepithelial IgG in the same RA sera. In these cases only the semiquantitative evaluation of the stratum comeum fluorescence intensity permitted diagnosis. This quantitative approach also allowed us to show that IgG antikeratin antibody diagnostic sensitivity and specificity were closely linked to their titre (Fig. 2B) . Indeed, up to a fluorescence intensity of 1-25 the specificity was considered insufficient (less than 95%), while from 2*25 the sensitivity became too weak for diagnostic use (less than 40%). To obtain the best compromise between sensitivity and specificity we chose 2-00 as a threshold because it allowed a diagnostic specificity of more than 99%. Thus for an individual serum a result below that threshold does not permit a diagnosis of RA to be excluded (low negative predictive value). At the threshold the diagnosis can be asserted with an error probability of 3-75% (high positive predictive value). Beyond the threshold the predictive value increases, and over a fluorescence intensity of 3 50 the test becomes pathognomonic for RA as the diagnosis can be asserted without computable error.
IgM antibodies
In contrast, IgM antibodies to this epithelium were present in almost all the serum samples with large interindividual variations in their labelling and in their titre. Moreover, no pattern specific for RA or for any other disease could be identified. Among them, IgM antikeratin antibodies, sometimes with a high titre, were found in RA as well as in non-RA sera and thus were clearly of no diagnostic value.
To summarise, the histological analysis of IgG antibodies to rat oesophagus epithelium permitted a histological pattern typical of RA specific IgG tIn the first two studies antikeratin antibodies were assayed using non-IgG specific antibodies, whereas in the second group of eight studies, as in this study, IgG specific antibodies were used. The tested sera were divided into four classes: RA, various other rheumatic diseases, miscellaneous non-rheumatic diseases, and normal control sera. Sensitivities and specificities were computed for each study and for each group of studies. [14] [15] [16] did not consider the labelling produced by the so-called negative sera and always regarded it as background fluorescence. So, the diagnostic sensitivity and specificity were imposed on the investigators by their previously chosen detection threshold. This is probably the main explanation of the differences in sensitivity and specificity they reported, but the variations in the assay procedures they used or in the composition of the patient samples they analysed, or both, can also explain these discrepancies. When antikeratin antibodies were investigated with non-IgG specific secondary antibodies able to detect all the immunoglobulin classes" 15 Significance of the tests is given as +=p<0-05; ++=p<0-01; +++=p<0-001; NS=non-significant; blank=not tested.
group.bmj.com on June 23, 2017 -Published by http://ard.bmj.com/ Downloaded from 3-04% (18/592) of the rheumatic non-RA sera. In our study the percentage of false positives among the rheumatic non-RA sera ranged from 4-57% to 0-86% when the chosen threshold ranged from 1-50 to 2-00.
The relations between IgG antikeratin antibodies and other clinical and serological indexes of RA investigated in our series (Table 4) were analysed together with those reported in previous studies (Table 6 ). From the whole series of results we compared IgG antikeratin antibody detection with other diagnostic tests for RA and attempted to determine whether the antikeratin antibody positive patients belonged to a particular subgroup of RA, with regard to the other indexes of the disease.
The incidence and titre of IgG antikeratin antibodies were found to be significantly correlated with IgM RF by all the authors who investigated such a correlation ,2 9 10 12 1917 and in both respects we agree with these results. As in previous studies 3 12 16 We think that indirect immunofluorescence detection of antikeratin antibodies should be used more widely. To ensure interlaboratory reproducibility, however, the following procedure should be used. The middle third of rat oesophagus must be used as substrate as it allows the best diagnostic sensitivity and specificity to be obtained.9 11 IgG antikeratin antibodies must be detected with secondary antibodies specific for human IgG to prevent the simultaneous detection of non-RA-specific IgM antikeratin antibodies. The histological labelling pattern must be analysed to identify false positive sera (Fig. 2C) . Evaluation of the titre, either semiquantitatively by fluorescence intensity or by a dilution titration method, is also necessary because the specificity depends on the titre, and also the classification as positive or negative of sera which do not present a typical histological pattern of labelling would become possible. Each laboratory will easily be able to establish its own reference standards with two samples of well characterised sera from patients with or without RA. A specific immunoassay is awaited, but meanwhile the various groups trained in this aspect of immunorheumatology could colla-borate to select reference sera, thus leading to 'oternational standardisation.
In conclusion, the diagnostic value of antikeratin antibodies has been assessed by 11 research groups working with 4080 patients, including 1694 with RA, coming from 10 places in five countries-that is, from genetically heterogeneous populations. Analysis of all the results obtained by us and other workers under comparable technical conditions2 8 12-14 16 17 shows that the mean diagnostic sensitivity of IgG antikeratin antibody detection is better than 46% and the mean specificity is near 98%. This test must, therefore, be considered as the most specific biological criterion for the diagnosis of RA, which actually becomes pathognomonic when IgG antikeratin antibodies are present in a high titre. IgG antikeratin antibodies are more specific for RA than are RFs, and, moreover, allow a high percentage of RF negative RA to be diagnosed. Furthermore, IgG antikeratin antibodies may have some prognostic significance as the subgroup of RA defined by high IgG antikeratin antibody titres seems to correspond to more severe or more active forms of the disease. It remains to be determined whether IgG antikeratin antibodies are present at a weak titre in all human sera and only increased in RA or whether they result from a synthesis specific for patients with RA. In the same way their possible pathogenic significance remains, to date, totally unexplored. 
